36010-89-6 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
1,3-Cyclopentanedicarboxylic acid, (1S-trans)(9CI) is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new drugs and pesticides.
Used in Polymer Chemistry:
1,3-Cyclopentanedicarboxylic acid, (1S-trans)(9CI) is used in the field of polymer chemistry, where it can be incorporated into the structure of polymers to modify their properties and enhance their performance.
Used in Biodegradable Plastics and Polymers Production:
1,3-Cyclopentanedicarboxylic acid, (1S-trans)(9CI) is used in the production of biodegradable plastics and polymers, which are environmentally friendly alternatives to traditional petroleum-based plastics.
Used in Asymmetric Synthesis:
As a chiral compound, 1,3-Cyclopentanedicarboxylic acid, (1S-trans)(9CI) has potential use in asymmetric synthesis, where it can be employed to selectively produce enantiomerically pure compounds, which are important in various applications, including pharmaceuticals and agrochemicals.
Used as a Chelating Agent in Chemical Processes:
1,3-Cyclopentanedicarboxylic acid, (1S-trans)(9CI) is used as a chelating agent in various chemical processes, where it can form stable complexes with metal ions, facilitating reactions and improving process efficiency.
Check Digit Verification of cas no
The CAS Registry Mumber 36010-89-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,0,1 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 36010-89:
(7*3)+(6*6)+(5*0)+(4*1)+(3*0)+(2*8)+(1*9)=86
86 % 10 = 6
So 36010-89-6 is a valid CAS Registry Number.
36010-89-6Relevant academic research and scientific papers
COMPOUNDS AND THEIR METHODS OF USE
-
, (2014/05/25)
Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that inhibit glutaminase in the treatment of cancer.
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES AS GLUTAMINASE INHIBITORS FOR TREATING CANCERS THEREOF
-
, (2014/06/11)
Provided are compounds of formula (I), wherein X, Y, Z, W, m, n, o, p, R1, R2 and R6 are defined as in the description. Pharmaceutical compositions and uses as glutaminase inhibitors for treating cancers thereof are also provided.
COMPOUNDS AND THEIR METHODS OF USE
-
, (2014/06/11)
Provided are compounds of formula (I), which can inhibit glutaminase. Pharmaceutical compositions comprising these compounds and uses as glutaminase inhibitors for treating cancers thereof are also provided.
